159 related articles for article (PubMed ID: 7739729)
1. Antifungal properties of essential oils and their main components upon Cryptococcus neoformans.
Viollon C; Chaumont JP
Mycopathologia; 1994 Dec; 128(3):151-3. PubMed ID: 7739729
[TBL] [Abstract][Full Text] [Related]
2. Use of Pinus sylvestris L. (Pinaceae), Origanum vulgare L. (Lamiaceae), and Thymus vulgaris L. (Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptible/not-susceptible Cryptococcus neoformans strains.
Scalas D; Mandras N; Roana J; Tardugno R; Cuffini AM; Ghisetti V; Benvenuti S; Tullio V
BMC Complement Altern Med; 2018 May; 18(1):143. PubMed ID: 29724221
[TBL] [Abstract][Full Text] [Related]
3. Antifungal and Cytotoxic Activities of Sixty Commercially-Available Essential Oils.
Powers CN; Osier JL; McFeeters RL; Brazell CB; Olsen EL; Moriarity DM; Satyal P; Setzer WN
Molecules; 2018 Jun; 23(7):. PubMed ID: 29954086
[TBL] [Abstract][Full Text] [Related]
4. Bigger Data Approach to Analysis of Essential Oils and Their Antifungal Activity against
Powers CN; Satyal P; Mayo JA; McFeeters H; McFeeters RL
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394798
[TBL] [Abstract][Full Text] [Related]
5. Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela.
Calvo BM; Colombo AL; Fischman O; Santiago A; Thompson L; Lazera M; Telles F; Fukushima K; Nishimura K; Tanaka R; Myiajy M; Moretti-Branchini ML
J Clin Microbiol; 2001 Jun; 39(6):2348-50. PubMed ID: 11376089
[TBL] [Abstract][Full Text] [Related]
6. [Antifungal activity of Caryocar brasiliensis (Caryocaraceae) against Cryptococcus neoformans].
Passos XS; Santos Sda C; Ferri PH; Fernandes Ode F; Paula Tde F; Garcia AC; Silva Mdo R
Rev Soc Bras Med Trop; 2002; 35(6):623-7. PubMed ID: 12612745
[TBL] [Abstract][Full Text] [Related]
7. Antifungal activity from Ocimum gratissimum L. towards Cryptococcus neoformans.
Lemos Jde A; Passos XS; Fernandes Ode F; Paula JR; Ferri PH; Souza LK; Lemos Ade A; Silva Mdo R
Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):55-8. PubMed ID: 15867965
[TBL] [Abstract][Full Text] [Related]
8. Timed-kill curves for Cryptococcus neoformans isolated from patients with AIDS.
Rodero L; Córdoba S; Cahn P; Soria M; Lucarini M; Davel G; Kaufman S; Canteros C; Guelfand L
Med Mycol; 2000 Jun; 38(3):201-7. PubMed ID: 10892987
[TBL] [Abstract][Full Text] [Related]
9. Differential killer toxin sensitivity patterns of varieties of Cryptococcus neoformans.
Boekhout T; Scorzetti G
J Med Vet Mycol; 1997; 35(2):147-9. PubMed ID: 9147276
[TBL] [Abstract][Full Text] [Related]
10. Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents.
Poonwan N; Mikami Y; Poosuwan S; Boon-Long J; Mekha N; Kusum M; Yazawa K; Tanaka R; Nishimura K; Konyama K
Eur J Epidemiol; 1997 Apr; 13(3):335-40. PubMed ID: 9258534
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of clinical isolates of Cryptococcus neoformans to amphotericin B using time-kill methodology.
Pappalardo MC; Szeszs MW; Martins MA; Baceti LB; Bonfietti LX; Purisco SU; Baez AA; Melhem MS
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):146-51. PubMed ID: 19345042
[TBL] [Abstract][Full Text] [Related]
12. Antifungal effects of herbal essential oils alone and in combination with ketoconazole against Trichophyton spp.
Shin S; Lim S
J Appl Microbiol; 2004; 97(6):1289-96. PubMed ID: 15546420
[TBL] [Abstract][Full Text] [Related]
13. Antifungal activity study of the monoterpene thymol against
Teixeira APC; Nóbrega RO; Lima EO; Araújo WO; Lima IO
Nat Prod Res; 2020 Sep; 34(18):2630-2633. PubMed ID: 30584769
[No Abstract] [Full Text] [Related]
14. Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida.
Mandras N; Nostro A; Roana J; Scalas D; Banche G; Ghisetti V; Del Re S; Fucale G; Cuffini AM; Tullio V
BMC Complement Altern Med; 2016 Aug; 16(1):330. PubMed ID: 27576581
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Córdoba S; Isla MG; Szusz W; Vivot W; Altamirano R; Davel G
Mycoses; 2016 Jun; 59(6):351-6. PubMed ID: 26865081
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility to antifungal agents of clinical and environmental Cryptococcus neoformans isolated in Southern of Brazil.
Alves SH; Oliveira LT; Costa JM; Lubeck I; Casali AK; Vainstein MH
Rev Inst Med Trop Sao Paulo; 2001; 43(5):267-70. PubMed ID: 11696849
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the antifungal activity of carvacrol against strains of Cryptococcus neoformans.
Nóbrega RO; Teixeira AP; Oliveira WA; Lima EO; Lima IO
Pharm Biol; 2016 Nov; 54(11):2591-2596. PubMed ID: 27225838
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial and antifungal activity of ten essential oils in vitro.
Pattnaik S; Subramanyam VR; Kole C
Microbios; 1996; 86(349):237-46. PubMed ID: 8893526
[TBL] [Abstract][Full Text] [Related]
19. In vitro control of post-harvest fruit rot fungi by some plant essential oil components.
Camele I; Altieri L; De Martino L; De Feo V; Mancini E; Rana GL
Int J Mol Sci; 2012; 13(2):2290-2300. PubMed ID: 22408454
[TBL] [Abstract][Full Text] [Related]
20. Essential oils and their components in combating fungal pathogens of animal and human skin.
Michalczyk A; Ostrowska P
J Mycol Med; 2021 Jun; 31(2):101118. PubMed ID: 33548912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
